Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03372057
Title A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma

anaplastic large cell lymphoma

mature T-cell and NK-cell lymphoma

Therapies

Duvelisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.